Market PositionWuXi Bio boasts 13% market share globally and 70% in China.
Revenue GrowthIf excluding COVID revenue, total revenue would increase by 37.7% YoY, and revenue from late-stage and CMO projects would surge by 101.7% YoY.
Share BuybackWuXi Bio has initiated a share repurchase plan with an aggregate value up to US$600mn, demonstrating management's confidence in the business.